Webinar Title
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor.
A closer look at MIT Tech Review's Predictions for AI-Led Drug Development. In this roundtable, Jason Sparapani interviews IQVIA and Calithera discussing the latest findings on how AI is reshaping the way drugs are brought to market.
Jason Sparapani
Content Manager, Insights
MIT Tech Review
25 minutes
Once a slow-paced, paper-first endeavor, drug research, is now a promising new frontier for AI-driven innovation, helping to bring life-saving drugs to market faster. It’s no small task. The estimated amount of health-care and life sciences data generated for each person in the world was 270GB as of 2020. That’s a huge volume of data to protect, keep compliant, and make sense of.
In this roundtable, Jason Sparapani will interview guests from IQVIA, Calithera, and Egnyte, to discuss the latest findings from MIT Tech Review and offer perspectives on how AI is reshaping the way drugs are brought to market.
Learn how AI accelerates drug development by:
Check out MIT Tech Review’s full report.